This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-outlook: Archive
BioCryst Pharmaceuticals (BCRX) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
BioCryst (BCRX) delivered earnings and revenue surprises of +400.00% and +9.74%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
BCRXPositive Net Change ZTSPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Krystal Biotech, Inc. (KRYS) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Krystal Biotech (KRYS) delivered earnings and revenue surprises of +19.44% and +6.12%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
KRYSNegative Net Change PHATPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Bruker (BRKR) Misses Q2 Earnings Estimates
by Zacks Equity Research
Bruker (BRKR) delivered earnings and revenue surprises of -3.03% and +0.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
BRKRNegative Net Change AVTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
TG Therapeutics (TGTX) Misses Q2 Earnings Estimates
by Zacks Equity Research
TG Therapeutics (TGTX) delivered earnings and revenue surprises of -46.88% and +3.75%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
TGTXNegative Net Change EXASPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Wayfair (W) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Wayfair (W) delivered earnings and revenue surprises of +141.67% and +4.25%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
WPositive Net Change CPNGNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Axsome Therapeutics (AXSM) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Axsome (AXSM) delivered earnings and revenue surprises of +8.00% and +7.47%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AXSMPositive Net Change IFRXPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Hagerty, Inc. (HGTY) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Hagerty (HGTY) delivered earnings and revenue surprises of +18.18% and +4.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
HGTYNegative Net Change HRTGPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Freshpet (FRPT) Tops Q2 Earnings Estimates
by Zacks Equity Research
Freshpet (FRPT) delivered earnings and revenue surprises of +175.00% and -1.25%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
FRPTPositive Net Change USFDPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Idexx Laboratories (IDXX) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Idexx (IDXX) delivered earnings and revenue surprises of +9.67% and +4.01%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
IDXXPositive Net Change OFIXPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
SiriusPoint (SPNT) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
SiriusPoint (SPNT) delivered earnings and revenue surprises of +17.86% and +3.90%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
SPNTPositive Net Change AIGNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
CNA Financial (CNA) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
CNA Financial (CNA) delivered earnings and revenue surprises of +30.85% and +3.47%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CNANegative Net Change ESNTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Energizer Holdings (ENR) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Energizer (ENR) delivered earnings and revenue surprises of +85.25% and +3.39%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ENRNegative Net Change VFFPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Waters (WAT) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Waters (WAT) delivered earnings and revenue surprises of +0.68% and +3.63%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
WATNegative Net Change AXGNPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Should You Buy, Sell, or Hold Innodata Stock Before Q2 Earnings? (Revised)
by Nilanshi Mukherjee
INOD's second-quarter performance is expected to have benefited from Gen AI momentum and key customer expansion.
CTSHNegative Net Change INFYNegative Net Change EXLSNegative Net Change INODPositive Net Change
artificial-intelligence earnings-outlook earnings-preview earnings-report tech-stocks
Flora Growth Corp. (FLGC) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Flora Growth (FLGC) delivered earnings and revenue surprises of -83.33% and +25.71%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
FLGCNegative Net Change ALURNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
TELUS Digital (TIXT) Q2 Earnings and Revenues Beat Estimates (Revised)
by Zacks Equity Research
TELUS Digital (TIXT) delivered earnings and revenue surprises of +20.00% and +5.93%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
TIXTNegative Net Change DBDPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Balchem (BCPC) Surpasses Q2 Earnings and Revenue Estimates (Revised)
by Zacks Equity Research
Balchem (BCPC) delivered earnings and revenue surprises of +1.60% and +1.41%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
BCPCPositive Net Change OECNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Tempus AI Stock Before Q2 Earnings Release: To Buy or Not to Buy?
by Urmimala Biswas
TEM surged 34.5% in Q2 on AI-driven deals and product momentum, but valuation and profit concerns linger ahead of earnings.
AZNPositive Net Change TXGNegative Net Change SOPHNegative Net Change TEMNegative Net Change
artificial-intelligence earnings-estimates-revisions earnings-outlook earnings-preview earnings-report earnings-streak earnings-surprise healthcare medical medical-devices smart-health
Hudson Tech (HDSN) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Hudson Tech (HDSN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
HDSNPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Spok (SPOK) Rating Upgrade to Buy
by Zacks Equity Research
Spok (SPOK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
SPOKPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About TowneBank (TOWN) Rating Upgrade to Buy
by Zacks Equity Research
TowneBank (TOWN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
TOWNPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Meta Platforms (META) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Meta Platforms (META) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
METANegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
What Makes LATAM (LTM) a New Strong Buy Stock
by Zacks Equity Research
LATAM (LTM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
LTMPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Colony Credit (BRSP) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Colony Credit (BRSP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
BRSPNo Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Apollo Commerical Finance (ARI) Rating Upgrade to Strong Buy
by Zacks Equity Research
Apollo Commerical Finance (ARI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
ARIPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank